Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Vigil (gemogenovatucel-T)
i
Other names:
Bi-shRNAfurin, bi-shRNAfurin/GMCSF augmented autologous tumor cell vaccine, IND14205, TGFbeta2 antisense + rhGMCSF vaccine, TAG vaccine, bi-shRNAfurin/GMCSF autologous tumor cell vaccine
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Gradalis
Drug class:
GM-CSF agonist, TGF-β1 inhibitor, TGF-β2 inhibitor
Related drugs:
‹
talimogene laherparepvec (9)
ONCOS-102 (1)
CG0070 (1)
BS001 (0)
allogeneic GM-CSF-secreting tumor cells (0)
GVAX leukemia vaccine (0)
GVAX lung cancer vaccine (0)
sargramostim (0)
filgrastim (0)
OrienX010 (0)
pexastimogene devacirepvec (0)
PSA/IL-2/GM-CSF vaccine (0)
allogeneic Myeloma GM-CSF Vaccine (0)
LY2157299 (3)
AIM-001 (0)
HCW9218 (0)
NCE 401 (0)
RG6440 (0)
YL-13027 (0)
SRK-181 (0)
ABBV-151 (0)
NIS793 (0)
GS 6624 (0)
miRNA-520f (0)
OT-101 (0)
talimogene laherparepvec (9)
ONCOS-102 (1)
CG0070 (1)
BS001 (0)
allogeneic GM-CSF-secreting tumor cells (0)
GVAX leukemia vaccine (0)
GVAX lung cancer vaccine (0)
sargramostim (0)
filgrastim (0)
OrienX010 (0)
pexastimogene devacirepvec (0)
PSA/IL-2/GM-CSF vaccine (0)
allogeneic Myeloma GM-CSF Vaccine (0)
LY2157299 (3)
AIM-001 (0)
HCW9218 (0)
NCE 401 (0)
RG6440 (0)
YL-13027 (0)
SRK-181 (0)
ABBV-151 (0)
NIS793 (0)
GS 6624 (0)
miRNA-520f (0)
OT-101 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login